888 results on '"Malyszko, Jolanta"'
Search Results
152. Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop
153. Post-contrast acute kidney injury following contrast enhanced computed tomography: real or overestimated threat?
154. P0745URINE TIMP-2 AND IGFBP-7- NEW BIOMARKERS OF KIDNEY INJURY IN MULTIPLE MYELOMA PATIENTS
155. P0627INTRAOPERATIVE DIALYSIS DURING LIVER TRANSPLANTATION IS SAFE AND BENEFICIAL
156. P0712TRANSGELIN AS A POTENTIAL MARKER OF RENAL IMPAIRMENT IN MULTIPLE MYELOMA PATIENTS
157. P1115MEDICAL WASTE MANAGEMENT - HOW INDUSTRY CAN HELP US TO PROTECT ENVIRONMENT AND MONEY
158. P0005TIME-VARYING DIALYSATE BICARBONATE CONCENTRATIONS CAN REDUCE PEAK INTRADIALTIC SERUM BICARBONATE CONCENTRATIONS
159. P0624INCREASED URINARY BIOMARKERS OF KIDNEY INJURY IN PATIENTS AFTER ALLOGENETICHEMATOPOETIC STEM CELL TRANSPLANTATION REFLECT KIDNEY DAMAGE EVEN IN NORMALN KIDNEY FUNCTION
160. P0868ZONULIN AS A THERAPEUTIC POTENTIAL BIOMARKER OF ANEMIA IN PATIENTS WITH MULTIPLE MYELOMA AND CHRONIC KIDNEY DISEASE
161. Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals
162. Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress
163. RHABDOMYOLYSIS – INDUCED ACUTE KIDNEY INJURY – AN UNDERESTIMATED PROBLEM
164. HOME DIALYSIS DURING COVID-19 OUTBREAK– IT IS WORTH TO CONSIDER
165. COMPARISON OF MOLECULAR AND SEROLOGICAL TESTS FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) IN POST-EXPOSURE EMPLOYEES OF THE NEPHROLOGY DEPARTMENT
166. Reply
167. Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation
168. Labile plasma iron levels in chronic hemodialysis patients treated by intravenous iron supplementation
169. Post-transplant lymphoproliferative disorder: risk factors and management
170. Visfatin and endothelial function in dialyzed patients
171. Coronary blood flow in patients with end-stage renal disease assessed by thrombolysis in myocardial infarction frame count method
172. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients
173. Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?
174. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease
175. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients
176. Value of the real-time myocardial contrast echocardiography for risk stratification and for the detection of significant coronary stenosis in patients with end-stage renal disease
177. Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography
178. Pioneer interview series
179. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention
180. Hepcidin, Iron Status, and Renal Function in Chronic Renal Failure, Kidney Transplantation, and Hemodialysis
181. Estimation of glomerular filtration rate in patients with normal serum creatinine undergoing primary PCI: is it really normal?
182. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?
183. Renal transplant recipients with coronary artery disease exhibit impairment in fibrinolysis and structural changes in carotid arteries
184. Adiponectin Is Related to CD146, a Novel Marker of Endothelial Cell Activation/Injury in Chronic Renal Failure and Peritoneally Dialyzed Patients
185. SOLUBLE CD-146 AND OTHER MARKERS OF ENDOTHELIAL CELL INJURY ARE ELEVATED IN PERITONEALLY DIALYZED AND NEPHROTIC PATIENTS
186. A PROSPECTIVE ANALYSIS OF HEMOSTASIS INSYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) WITH ACUTE RENAL FAILURE
187. EFFECTS OF DIFFERENT HEPARINS ON THROMBIN ACTIVATABLEFIBRINOLYSIS INHIBITOR-TAFI IN HEMODIALYZED PATIENTS
188. A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients
189. Intravenous iron therapy and the cardiovascular system: risks and benefits.
190. Summary of the International Conference on Onco-Nephrology: an emerging field in medicine
191. Hypertension and chronic kidney disease is highly prevalent in elderly patients with colorectal cancer undergoing primary surgery
192. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA
193. Mild cognitive impairment and kidney disease: clinical aspects
194. Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease
195. Peritoneal Ultrafiltration in the Long-Term Treatment of Chronic Heart Failure Refractory to Pharmacological Therapy
196. Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
197. Author Correction: Lipid management in patients with chronic kidney disease
198. Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop
199. A15199 Resistant hypertension in dialyzed patients- how to define it properly
200. A15197 Hypertension in acute kidney injury is prevalent and depend on the origin of kidney injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.